EXCELLENT RESPONSE FOR POOR PROGNOSIS OSTEOSARCOMA PATIENTS WITH COMBINATION ZOLEDRONIC ACID, IFOSFAMIDE, BEVACIZUMAB, AND ETOPOSIDE
PEDIATRIC BLOOD & CANCER（2011）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined